We have developed a new murine model of toxoplasmic encephalitis based
on the intracerebral inoculation of tachyzoites of the highly virulen
t RH strain of Toxoplasma gondii. Intracerebral infection resulted in
a mortality of 100% on day five. Large inflammatory abscessed infiltra
tes developed by the second day after inoculation and expanded through
out the remaining period of observation. Numerous tachyzoites were det
ectable in brain parenchyma by the second day of infection. The marked
and precocious histopathological brain lesions produced by the RH str
ain are useful to detect therapeutic rather than prophylactic effects
of drugs against toxoplasmic encephalitis. In this model pyrimethamine
, sulphadiazine and its combination were useful in terms of mortality,
histopathology and spread of infection whereas clindamycin showed no
activity. This murine model of toxoplasmic encephalitis is useful to e
valuate antitoxoplasma agents with high therapeutic activity.